Reducing Leakage and Pain During Procedures
[by Ji, Yong Jun] Huons Meditech, a medical device company under the Huons Group, is strengthening its competitiveness in the skin booster market by introducing a premium 바카라 라바카지노 for enhanced treatment performance.
On the 20th, Huons Meditech (CEO Jinsuk Lee) announced the launch of its new sterile injection 바카라 라바카지노, the ‘Premium 9-Pin 바카라 라바카지노 31G,’ designed to minimize drug leakage and pain during skin booster treatments.
The ‘Premium 9-Pin 바카라 라바카지노 31G’ is a single-use, multi-sterile 바카라 라바카지노 exclusively compatible with Huons Meditech’s signature product, the ‘Derma Shine,’ a precision drug delivery device. Derma Shine has achieved cumulative sales of over 20,000 units, leading the targeted drug injection market.
This new 바카라 라바카지노 has been specifically developed for treatments involving skin boosters such as Juvelook, Rejuran, and Olidia. It is optimized for highly viscous ingredients like poly-L-lactic acid (PLLA), poly(D,L-lactic acid), and polydeoxyribonucleotide (PDRN), ensuring minimal pain and leakage during injection.
Leveraging Huons Meditech’s extensive manufacturing expertise, the ‘Premium 9-Pin 바카라 라바카지노 31G’ features a unique design that modifies the bevel length and 바카라 라바카지노 structure. Internal and external tests have confirmed its effectiveness in reducing both leakage and pain. The 바카라 라바카지노 also includes precision markings to control penetration depth accurately and a protective cap for enhanced safety and convenience for medical professionals.
Jinsuk Lee, CEO of Huons Meditech, stated, “With the launch of the ‘Premium 9-Pin 바카라 라바카지노 31G,’ we aim to minimize discomfort for patients and improve convenience for medical practitioners. Moving forward, we will continue to prioritize quality as our top value and strive to provide the best service to our customers.”
This new product is expected to further solidify 바카라 라바카지노 Meditech’s position in the skin booster market by offering a combination of precision, safety, and comfort.